Overview
ANL market data
Price History
ANL price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.37 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.35 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.88 – $17.25 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $530.4 · P/B 3.89.
Company news
Adlai Nortye Doses First Patient In The Intermittent Weekly Dosing Arm In Its Ongoing Phase 1 Clinical Trial Of AN9025, A Pan-RAS(ON) InhibitorBenzinga · Jul 16, 2026, 11:04 AM
Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · Jun 30, 2026, 12:05 PM
Cantor Fitzgerald Initiates Coverage On Adlai Nortye with Overweight RatingBenzinga · Jun 22, 2026, 1:25 PM
Oppenheimer Initiates Coverage On Adlai Nortye with Outperform Rating, Announces Price Target of $32Benzinga · May 28, 2026, 5:59 PM
Jones Trading Initiates Coverage On Adlai Nortye with Buy Rating, Announces Price Target of $22Benzinga · May 14, 2026, 8:31 PM